Details for New Drug Application (NDA): 040845
✉ Email this page to a colleague
NDA 040845 describes BENZPHETAMINE HYDROCHLORIDE, which is a drug marketed by Avet Lifesciences, Chartwell, Epic Pharma Llc, Impax Labs, Kvk Tech, Scinopharm Taiwan, Specgx Llc, and Tedor Pharm, and is included in nine NDAs. It is available from five suppliers. Additional details are available on the BENZPHETAMINE HYDROCHLORIDE profile page.
The generic ingredient in BENZPHETAMINE HYDROCHLORIDE is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
The generic ingredient in BENZPHETAMINE HYDROCHLORIDE is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
Summary for 040845
| Tradename: | BENZPHETAMINE HYDROCHLORIDE |
| Applicant: | Impax Labs |
| Ingredient: | benzphetamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040845
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Nov 18, 2008 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
